Supernus Pharmaceuticals Inc (SUPN)
35.82
-0.30
(-0.83%)
USD |
NASDAQ |
Nov 21, 16:00
41.99
+6.17
(+17.23%)
Pre-Market: 09:11
Supernus Pharmaceuticals Total Assets (Quarterly): 1.343B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.343B |
| June 30, 2024 | 1.316B |
| March 31, 2024 | 1.304B |
| December 31, 2023 | 1.278B |
| September 30, 2023 | 1.285B |
| June 30, 2023 | 1.293B |
| March 31, 2023 | 1.792B |
| December 31, 2022 | 1.703B |
| September 30, 2022 | 1.693B |
| June 30, 2022 | 1.695B |
| March 31, 2022 | 1.640B |
| December 31, 2021 | 1.689B |
| September 30, 2021 | 1.555B |
| June 30, 2021 | 1.573B |
| March 31, 2021 | 1.507B |
| December 31, 2020 | 1.504B |
| September 30, 2020 | 1.510B |
| June 30, 2020 | 1.491B |
| March 31, 2020 | 1.190B |
| December 31, 2019 | 1.160B |
| September 30, 2019 | 1.107B |
| June 30, 2019 | 1.064B |
| March 31, 2019 | 1.025B |
| December 31, 2018 | 977.81M |
| September 30, 2018 | 922.51M |
| Date | Value |
|---|---|
| June 30, 2018 | 852.80M |
| March 31, 2018 | 825.16M |
| December 31, 2017 | 424.46M |
| September 30, 2017 | 385.48M |
| June 30, 2017 | 346.37M |
| March 31, 2017 | 322.26M |
| December 31, 2016 | 309.57M |
| September 30, 2016 | 285.12M |
| June 30, 2016 | 218.63M |
| March 31, 2016 | 194.47M |
| December 31, 2015 | 188.63M |
| September 30, 2015 | 166.77M |
| June 30, 2015 | 154.17M |
| March 31, 2015 | 139.64M |
| December 31, 2014 | 136.78M |
| September 30, 2014 | 126.32M |
| June 30, 2014 | 94.19M |
| March 31, 2014 | 97.52M |
| December 31, 2013 | 111.00M |
| September 30, 2013 | 123.76M |
| June 30, 2013 | 131.97M |
| March 31, 2013 | 79.06M |
| December 31, 2012 | 93.99M |
| September 30, 2012 | 67.01M |
| June 30, 2012 | 79.96M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.160B
Minimum
Dec 2019
1.792B
Maximum
Mar 2023
1.476B
Average
1.506B
Median
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 37.44B |
| United Therapeutics Corp | 7.123B |
| Ligand Pharmaceuticals Inc | 954.87M |
| Tonix Pharmaceuticals Holding Corp | 94.99M |
| Agios Pharmaceuticals Inc | 1.792B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 335.55M |
| Shareholders Equity (Quarterly) | 1.007B |
| Current Ratio | 2.196 |